Literature DB >> 3332804

Charcot on Parkinson's disease.

C G Goetz1.   

Abstract

Charcot saluted Parkinson for his early observations, but condemned his use of the term "paralysis agitans." He emphasized that patients were neither dramatically weak nor were they necessarily plagued with tremor. Charcot suggested the name "Parkinson's disease," although he could not resist the comment in his amphitheater lecture series at the Salpêtrière that French physicians (unnamed) had probably described the disorder before 1817. Tremor, rigidity, postural instability, and bradykinesia were all recognized by Charcot. He classified the disorder as a "névrose," meaning a neurologic disorder without a known pathologic lesion, and found little benefit from therapies available at the time, including belladonna and ergot products.

Entities:  

Mesh:

Year:  1986        PMID: 3332804     DOI: 10.1002/mds.870010104

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  10 in total

Review 1.  Rodent models and contemporary molecular techniques: notable feats yet incomplete explanations of Parkinson's disease pathogenesis.

Authors:  Sharawan Yadav; Anubhuti Dixit; Sonal Agrawal; Ashish Singh; Garima Srivastava; Anand Kumar Singh; Pramod Kumar Srivastava; Om Prakash; Mahendra Pratap Singh
Journal:  Mol Neurobiol       Date:  2012-06-27       Impact factor: 5.590

2.  Visual assessment of dopaminergic degeneration pattern in 123I-FP-CIT SPECT differentiates patients with atypical parkinsonian syndromes and idiopathic Parkinson's disease.

Authors:  Deniz Kahraman; Carsten Eggers; Harald Schicha; Lars Timmermann; Matthias Schmidt
Journal:  J Neurol       Date:  2011-07-13       Impact factor: 4.849

Review 3.  Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson's disease.

Authors:  Bin Liu
Journal:  AAPS J       Date:  2006-09-29       Impact factor: 4.009

Review 4.  Lewy Body Degenerations as Neuropsychiatric Disorders.

Authors:  Jared T Hinkle; Gregory M Pontone
Journal:  Psychiatr Clin North Am       Date:  2020-04-08

5.  The Demise of Poskanzer and Schwab's Influenza Theory on the Pathogenesis of Parkinson's Disease.

Authors:  Danny Estupinan; Sunina Nathoo; Michael S Okun
Journal:  Parkinsons Dis       Date:  2013-06-11

6.  A case of Charcot's feet in a patient with Parkinson's disease: a case report.

Authors:  Amresh P Singh; Andrew J Kelly
Journal:  Cases J       Date:  2009-11-09

7.  Whose name is it anyway? Varying patterns of possessive usage in eponymous neurodegenerative diseases.

Authors:  Michael R Macaskill; Tim J Anderson
Journal:  PeerJ       Date:  2013-04-16       Impact factor: 2.984

Review 8.  Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease.

Authors:  Daniela Maria Vogt Weisenhorn; Florian Giesert; Wolfgang Wurst
Journal:  J Neurochem       Date:  2016-06-27       Impact factor: 5.372

Review 9.  Is insulin-like growth factor-1 involved in Parkinson's disease development?

Authors:  Inma Castilla-Cortázar; Gabriel A Aguirre; Giovana Femat-Roldán; Irene Martín-Estal; Luis Espinosa
Journal:  J Transl Med       Date:  2020-02-11       Impact factor: 5.531

Review 10.  The Universal Prescription for Parkinson's Disease: Exercise.

Authors:  Jay L Alberts; Anson B Rosenfeldt
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.